Prime Medicine, Inc. (PRME) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$3.70
—
Mkt Cap $668.04M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | $1.29M | $842.00K | -34.60% | -$0.25 | -$0.22 | +12.00% | — | — |
| Q4 2025 Nov 7, 2025 | $2.05M | $1.23M | -40.28% | -$0.28 | -$0.32 | -14.29% | — | — |
| Q3 2025 Aug 7, 2025 | $2.80M | $1.11M | -60.19% | -$0.36 | -$0.41 | -13.89% | — | — |
| Q2 2025 May 8, 2025 | $2.33M | $1.45M | -37.69% | -$0.32 | -$0.40 | -25.00% | — | — |
| Q1 2025 Feb 28, 2025 | $6.78M | $2.18M | -67.82% | -$0.37 | -$0.31 | +16.22% | — | — |
| Q4 2024 Nov 12, 2024 | $7.09M | $209.00K | -97.05% | -$0.43 | -$0.44 | -2.33% | — | — |
| Q3 2024 Aug 8, 2024 | $1.63M | $37.77M | +2217.42% | -$0.40 | -$0.46 | -15.00% | — | — |
| Q2 2024 May 10, 2024 | $1.92M | $591.00K | -69.25% | -$0.45 | -$0.44 | +2.22% | — | — |
| Q1 2024 Mar 1, 2024 | $5.71M | — | — | -$0.48 | -$0.56 | -16.67% | — | — |
| Q4 2023 Nov 3, 2023 | $1.67M | — | — | -$0.45 | -$0.55 | -22.22% | — | — |
| Q3 2023 Aug 7, 2023 | — | — | — | -$0.42 | -$0.47 | -11.90% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.42 | -$0.44 | -4.76% | — | — |
| Q1 2023 Mar 9, 2023 | — | — | — | -$0.65 | -$0.56 | +13.85% | — | — |
| Q4 2022 Oct 21, 2022 | — | — | — | -$0.71 | -$0.38 | +47.05% | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.50 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.42 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.86 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.32 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $9.13M | — | — | $0.05 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$11.82 | — | — | — |
| Q1 2021 Jan 1, 2021 | — | — | — | — | -$0.04 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$0.04 | — | — | — |